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The different phases of the eukaryotic cell cycle are exceptionally well-preserved
phenomena. DNA decompaction, RNA and protein synthesis (in late G1 phase)
followed by DNA replication (in S phase) and lipid synthesis (in G2 phase) occur after
resting cells (in G0) are committed to proliferate. The G1 phase of the cell cycle is
characterized by an increase in the glycolytic metabolism, sustained by high NAD+/NADH
ratio. A transient cytosolic acidification occurs, probably due to lactic acid synthesis or
ATP hydrolysis, followed by cytosolic alkalinization. A hyperpolarized transmembrane
potential is also observed, as result of sodium/potassium pump (NaK-ATPase) activity.
During progression of the cell cycle, the Pentose Phosphate Pathway (PPP) is activated
by increased NADP+/NADPH ratio, converting glucose 6-phosphate to nucleotide
precursors. Then, nucleic acid synthesis and DNA replication occur in S phase.
Along with S phase, unpublished results show a cytosolic acidification, probably
the result of glutaminolysis occurring during this phase. In G2 phase there is a
decrease in NADPH concentration (used for membrane lipid synthesis) and a
cytoplasmic alkalinization occurs. Mitochondria hyperfusion matches the cytosolic
acidification at late G1/S transition and then triggers ATP synthesis by oxidative
phosphorylation. We hypothesize here that the cytosolic pH may coordinate
mitochondrial activity and thus the different redox cycles, which in turn control
the cell metabolism.
Keywords: Cell cycle, CCM, REDOX, Intracellular pH, ATP/ADP, NAD(P)+/NAD(P)H,
HATs, HDACsBackground
For several years now, a number of studies have been conducted, in the field of the
bioenergetic origin of life [1]. Bioenergetics consists in converting nutrients such as
carbohydrates, lipids, and proteins, into intermediate metabolites as well as energy for
cell survival and finally into de novo building blocks such as nucleic acids, proteins and
lipids for cell proliferation. More broadly, cell metabolism is the sum of all the chemical
reactions and dynamic exchanges between a cell and its microenvironment. Eukaryotic
cells, at least, exhibit two opposite metabolisms: anabolic reactions, which consist in bio-
mass synthesis and catabolic reactions, leading to the breakdown of macromolecules for
energetic use. These two aspects of cell metabolism are managed by biochemical and bio-
physical oscillators, including reductive and oxidative (redox) couples, the most import-
ant ones being Nicotinamide Adenine Dinucleotide (NAD+/NADH) and Nicotinamide© 2015 da Veiga Moreira et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution
License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium,
provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://
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Triphosphate (ATP/ADP), the transmembrane potential (Vm) and, last but not least, the
intracellular pH (pHi) of the cell. The dynamics of these internal biological rhythms are
shown to exhibit oscillatory phenotypes in dividing cells [2].
The intriguing metabolic feature of proliferating cells compared with quiescent ones
highlights the well-conserved sequential events characterizing the eukaryotic cell cycle.
From the point of view of the central carbon metabolism (CCM), (Fig. 1), the quiescent
cells (in G0) have a basal oxidative metabolism, whereas, in proliferating cells, the car-
bon flux is rewired to biomass synthesis and cell growth [3]. The latter is enhanced by
a high glycolytic rate consuming NAD+ and ADP species for cytoplasmic glucose con-
version into pyruvate, generating NADH and ATP molecules. NADH is oxidized back
to NAD+ through pyruvate conversion into lactate, termed as the Warburg effect after
the German Nobel laureate Otto Warburg, and ATP is used as an energy supplier for
RNA and protein synthesis in G1 of the cell cycle. Glycolysis is then shunted to the pen-
tose phosphate pathway (PPP), generating nucleic acid precursors for DNA replication in
the S phase and NADPH reductive species used later on in the cell cycle progression for
membrane lipid synthesis in G2. The G2 phase is also characterized by full mitochondrial
activity, where the citric acid cycle takes place, enabling glucose oxidation and ATP
synthesis.
Moreover, current hypothesis support the proton gradient-dependent ATP hydrolysis
and synthesis into the cytosol and mitochondria, respectively, as critical events in both
transmembrane potential and intracellular pH oscillation during cell cycle. In this study
we aim at juxtaposing interesting results confirming the hypothesis of the pivotal role
of pHi on mitochondrial activity and the resulting redox oscillations timing the pro-
gression of the cell cycle. For that, we first report the redox phenomena involved in
central carbon metabolism and how it regulates the metabolic transitions during the
cell cycle progression. Secondly, based on literature reports, we highlight intracellular
pH role in cell metabolism and its potential involvement in “clocking” transitions during
the cell cycle.Cellular redox transitions in CCM during cell cycle progression
1. The metabolic status of quiescent cells in G0
Quiescent cells have a basal oxidative metabolism [3]. They use nutrients such as
glucose, protein and fatty acids as main energy supplier to support primary reactions
such as amino acids and nucleotide synthesis (see Fig. 1-a) [4]. For that, the glycolytic
pathway converts glucose to pyruvate and produces the universal energy transporter in
living systems, adenosine triphosphate (ATP). Pyruvate can either be converted into
lactate, in the cytosol, or join the tricarboxylic acid (TCA) cycle, taking place in mito-
chondria. There, ATP is synthesized by oxidative phosphorylation. On the other hand,
macromolecules such as proteins and fatty acids are also degraded and join mitochon-
dria for full conversion to ATP, carbon dioxide (CO2) and water [3]. The electrochem-
ical energies released during these catabolic reactions are captured by electron carrier
species such as nicotinamide adenine nucleotide (NAD+), converting it to its respective
reduced partner (NADH,H+). NADH,H+ is the electron donor of the mitochondrial
electron transport chain (ETC.) during oxidative phosphorylation. It is not clear if NADH
a b
c d
Fig. 1 The central carbon metabolism (CCM). a The different phases of the eukaryotic cell cycle could be
explain by reductive-oxidative (redox) transitions in the CCM. b In G1, high ATP demand for protein
synthesis is managed by anaerobic glycolysis leading to lactate synthesis. This permits NAD+ regeneration
by lactate dehydrogenase and then sustains high NAD+/NADH ratio. c In S phase, the CCM is shifted to
pentose phosphate pathway (PPP) for nucleotide synthesis. d In G2 the tricarboxylic acid (TCA) pathway
and the electron transport chain are fully active and allow mitochondrial ATP synthesis and lipid synthesis
from citrate
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such as the malate/citrate shuttle allows mitochondrial NADH regeneration through the
TCA cycle [5] (see Fig. 1-a). This basal metabolism allows homeostatic control of high
NAD+/NADH and low NADP+/NADPH redox ratios [6] in resting cells. On the opposite,
in proliferating cells, the basal catabolic metabolism is shifted to anabolism and exhibit
oscillatory conversion of these redox species for biomass synthesis and cell growth [3]
(see Fig. 2).
2. Redox oscillation in dividing cells
2.1. Cell cycle entry into G1 is regulated by the Warburg effect Glycolysis is one of
the fundamental pathways of living organisms. It allows the conversion of one molecule
of glucose into two pyruvates. During this process, universal energy transporters, such
as ATP and NADH, are produced from the oxidative conversion of ADP and NAD+,
respectively. This pathway is characterized by two phases: the so-called “investment”
phase, since it consumes two ATP molecules, and the “payoff” phase, which produces
four ATP. The first phase consists in catabolizing one molecule of glucose into two
Fig. 2 The logic of metabolic cell cycle. Cytosolic NAD+/NADH, NADP+/NADPH, ATP/ADP ratios and
intracellular pH (pHi) are reported to oscillate through eukaryotic cell cycle. Mitosis is often described as a
catastrophic event where microtubule depolymerization and ATP-dependent pumps « burn » the ATP stock
by ATP hydrolysis. This decreases the ATP/ADP ratio. In parallel, the intracellular pH is reported to decrease
and reaches its stationary phase in quiescent cells (G0). To our knowledge, there are no data on NAD
+/NADH and NADP+/NADPH redox ratios during mitosis. In early G1 phase the increased glycolytic
pathway matches a transient acidic pHi before cytosol alkalinization. This is often assumed to be linked to
lactate synthesis. Lactate dehydrogenase enzyme catalyses pyruvate conversion to lactic acid by using
NADH as coenzyme. NAD+/NADH ratio is high in G1 and decreases until reaching its minimal value in S
phase. NADPH consuming pathway such as ROS conversion to reduced species is known to trigger cell
cycle entry and enhances PPP by increasing the NADP+/NADPH redox ratio in S phase. This is a necessary
step for nucleic nucleotide synthesis. During this phase cytosolic acidification, probably due to
glutaminolysis, meets hyperfused mitochondria where ATP synthesis takes place. NAD + −dependent
histone synthesis is thought to decrease the NAD+/NADH ratio. In G2, both free ATP concentration and pHi
reach their maximal value, high and alkaline, respectively. NADPH consumption during fatty acids synthesis
may increase NADP+/NADPH ratio in G2. NAD+/NADH ratio is reported to increase in G2. This could be
explain by increased shuttling pathways such as malate/citrate one, permiting NAD+ synthesis from
oxaloacetate to malate conversion
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two pyruvates that will later play a pivotal role in mitochondria-dependent energy pro-
duction. In one study, Diaz-Moralli and colleagues (2012) assume that the glycolytic
pathway mainly occurs during the first growth phase of the eukaryotic cell cycle (G1)
[7]. Indeed, in G1 cells grow and synthesize messenger RNA (mRNA) for protein syn-
thesis. Moreover, these studies [8–10] reported the aerobic glycolysis to follow bio-
chemical principles based on “thermodynamic favorability, availability of enzymatic
mechanisms and the physicochemical properties of pathway intermediates”, meeting
the cells’ energy demands for cell proliferation.
High glycolytic flux in central carbon metabolism (CCM) occurs when quiescent cells
are committed to proliferation [3]. High ATP demand for protein synthesis meets high
NAD+/NADH redox ratio, allowing glycolysis to persist through the fermentative
pyruvate to lactate conversion by lactate dehydrogenase enzyme (Fig. 1-b). This
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glycolytic phosphorylation, in non-transformed proliferating cells, entering cell cycle
[11, 12]. Calderon-Montano and colleagues [11] highlighted the intracellular pH (pHi)
role in regulating glycolytic genes such as phosphofructokinase-1 (PFK-1). Increased
pHi such as observed in cancer cells increases biomass (DNA and protein) synthesis.
This anabolic metabolism observed in rapidly-proliferating cells results in redox oscilla-
tions of cytoplasmic free ATP concentration, as well as the NAD+/NADH ratio [13, 14]
(Fig. 2). It sustains the aerobic glycolysis observed in G1, just as described by Otto Heinrich
Warburg in its seminal work on the glycolytic mode of cancer metabolism [15]. Interest-
ingly, recent studies provide explanations of the Warburg effect, from quantitative models
of the metabolic shift in cancer cells, which has the same metabolic signature as normal-
proliferating cells in G1 phase [16–18]. These are based on analytic rules deciphering
the dualistic aspect of proliferating cells metabolism where the abundant resource
triggering cell cycle entry favors the glycolytic phenotype, referred as Warburg effect
in cancerous tissue. In short, the Warburg effect drives the volumetric growth in G1
by “metabolosomic” biomass synthesis whereas mitochondria activity triggers the
surfacic growth.
It is noteworthy that this biphasic growth taking place in proliferating cells is under
the control of growth stimuli and redox species oscillation [19, 20]. In mammalian cells,
growth factors and their respective receptors are reported to generate ROS and trigger cell
cycle entry [7, 21, 22]. Therefore, moderate ROS formation in late G1 is essential for gene
transcription and protein synthesis, by modulating DNA accessibility [7]. In fact, an ex-
tensive number of studies support that histone acetylation is a pivotal epigenetic pro-
gram controlling eukaryotic gene transcription [23–25]. In short, transcriptionally
active genes are shown to meet hyperacetylated histones, while the “hypoacetylated
histone is associated with transcriptionally repressed genes” [25, 26]. Firstly, it is
shown that the cytoplasmic NAD+/NADH redox ratio optimizes the glycolytic flux
(Warburg effect) to ATP and amino acid synthesis. Secondly ATP is used as a supplier
of energy for gene transcription and protein synthesis, using these amino acids as
building blocks.
2.2. NADP+/NADPH ratio regulates the pentose phosphate pathway In normal pro-
liferating cells, one of the first pathways switched on after aerobic glycolysis, is the
pentose phosphate pathway (PPP) (Fig. 1-c). This is the main circuit for DNA precursor
synthesis and nicotinamide adenine dinucleotide phosphate (NADPH) regeneration, a
coenzyme used by the cell for lipid synthesis, in G2, and plays the role of reactive
oxygen species (ROS) scavenger in G1/S transition phase [7, 27–29]. The PPP is charac-
terized by two branches: the oxidative branch, where NADP+ is reduced to NADPH by
the shunt of glycolysis from glucose 6-phosphate (G6P) conversion into ribulose 5-
phosphate (R5P) [30], and the non-oxidative branch rewiring the PPP to aerobic gly-
colysis up to fructose 6-phosphate (F6P) and glyceraldehyde 3-phosphate (G3P).
Interestingly, the PPP has been shown to be regulated by the NADP+/NADPH
ratio [27, 31, 32]. Therefore, glucose 6-phosphate dehydrogenase (G6PDH) enzyme,
catalyzing the conversion of G6P into 6-phosphogluconolactone, has been shown to
have an allosteric activity, modulated by the cytoplasmic NADP+/NADPH ratio
[31]. This is in agreement with these studies [27, 32], which assume that the
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sult of cellular NADPH consumption by reactive oxygen species (ROS) in S phase.
In this study [29] on changes in the activity of the PPP, the authors showed that
NADPH-consuming pathways enhance the pentose phosphate cycle (Fig. 2-c). At
least two significant pathways have been identified as major NADPH consuming
systems: the glutathione redox cycle (GSH/GSSH) and the lipid synthesis pathway
[6, 33, 34]. The reduced glutathione (GSH) is a protective and antioxidant agent
that reduce reactive oxygen species (ROS), used in signaling cascades to trigger cell
cycle entry (see above) [7], and generates the oxidative species (GSSH). NADPH
reduces GSSH and, as a result, they both are converted back to their respective oxi-
dative “partner”, GSH and NADP+. In doing so, the glutathione redox cycle en-
hances the primary pathway using NADP+ as a coenzyme: the PPP oxidative
branch. The second NADPH-consuming pathway is lipid synthesis, which builds
fatty acid blocks from acetyl-CoA.
3. Mitochondria and their pivotal role in cell anabolic demand in G2
Mitochondrial activity is a key in cell metabolism decision-making and cell cycle pro-
gression. As it has been extensively reviewed in this study [35], mitochondria are organ-
elles that have been the subject of many controversies. They were first considered as
just a “powerhouse” of the eukaryotic cell, before the pioneering studies deciphering
their key role in processes such as development, survival, division, and cell death.
Regarding cell division, investigations support and highlight the idea of intertwined
relationships between machineries governing mitochondrial dynamics and cell cycle
metabolism [36, 37]. It has then been demonstrated that energy transitions occurring
in the cell cycle are intrinsically linked to mitochondria sensing parameters, such as the
intracellular pH (pHi) [38] and ATP/ADP ratio [39–41].
Recent studies highlight the mitochondrial morphogenesis at the G1/S transition of
the cell cycle. It is also shown that at the G1/S checkpoint, mitochondria form a single
giant factory for ATP synthesis [5, 42]. “This energetic boost” is thought to be necessary
to increase cyclin E expression in order for the cell to pass the G1/S checkpoint [41].
As stated above, this event could also be interpreted as a necessary step in cell energy
supply for protein, nucleic acid, and membrane lipid synthesis (Fig. 1-d). Interestingly
enough, these bodies of works support the idea of cell cycle progression meeting the
tricarboxylic acid (TCA) cycle and oxidative phosphorylation in S/G2 phase transition
[7]. The TCA or Krebs cycle, which takes place in mitochondria, in conjunction with
oxidative phosphorylation, does indeed allow for carbohydrate oxidation to CO2, H2O
and TCA intermediate species. This is also the most efficient route for ATP and lipid
precursors’ synthesis in the mitochondrial matrix.
The pyruvate accumulated in the cytosol from glycolysis passes through the recently
identified specific mitochondrial pyruvate carrier (MPC) and is converted into acetyl-
CoA [43–45]. This reaction is catalyzed by pyruvate dehydrogenase with NAD+ as co-
enzyme. The first step in the TCA cycle is acetyl-CoA conversion into citrate through
dehydration. According to the metabolic state of the cell, citrate can shunt to lipid
synthesis or continue the Krebs cycle (Fig. 1-d). For that, key enzymes are regulated by
negative feedback loops [46]. This includes citrate synthase, isocitrate dehydrogenase
and α-ketoglutarate dehydrogenase. These enzymes are down-regulated by NADH and
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sists of a series of biochemical reactions by which the glutamine amino acid is lysed into
glutamate and then α-ketoglutarate. From there, there are two possibilities: the oxidative
route enables the full Krebs cycle and conversion of α-ketoglutarate into succinyl-CoA
[47]. The reductive route is the α-ketoglutarate conversion to isocitrate and then citrate,
the precursor of lipid synthesis. It is interesting to note the reported negative regulation of
citrate synthase by succinyl-CoA [46]. Also noteworthy here, is that reductive versus oxi-
dative metabolism mutually exclude each other [48]. At the same time, ATP synthesis
through the oxidative phosphorylation chain is required for membrane lipid synthesis in
the second growth phase (G2) (see Fig. 1-d) [7].
Oxidative phosphorylation mainly occurs in the internal membrane of the mito-
chondria in eukaryotic cells. It uses TCA cycle precursors and co-enzymes, such as
NADH and FADH2, as electron donors for respiration. Through a cascade of reac-
tions, the ETC. complexes trigger the pumping of protons out of the matrix and en-
able a pH gradient (ΔpH) required for ATP synthesis (Fig. 3) [49]. In this redox
chain, molecular oxygen (O2) is used as the ultimate electron acceptor and ATP is
generated as protons moves down its concentration gradient through a well
evolutionary-conserved enzyme called ATP synthase, in the inner membrane of
mitochondria (reviewed here [49]. This chemiosmotic theory, developed by P.
Mitchell [50], explains how NADH and FADH2 oxidation are coupled to ADP phos-
phorylation into ATP. This is a coupling between oxidation and phosphorylation by
a proton gradient across the inner mitochondrial membrane. The oxidative energy
from NADH is converted into osmotic energy by proton gradient formation across
the membrane, where the intermembrane space is more acidic and the matrix is al-
kaline. The ΔpH, which is the pH difference between the matrix and the intermem-
brane space, is generated by enzymatic complexes of the ETC. Five complexes have
been identified. Only complexes I, III, IV are proton extruders. Four protons are
extruded by complexes I and IV and two protons for complex II. The last complex
is the ATP synthase catalyzing ADP phosphorylation into ATP against three protons
diffusing back to the mitochondrial matrix.
As stated above, the mitochondrial respiratory chain is mainly fueled by the
NAD+/NADH redox couple. In order for the proliferative cell to maintain high
ATP synthesis for cytoskeletal dynamics and membrane lipid synthesis, a symbi-
otic structure is formed between cytosol and the mitochondria. These are the
metabolic shuttles, where one of the most important ones being the malate/citrate
shuttle (Fig. 1-d). In fact, while mitochondrial ATP synthesis is high in G2, citrate
is shuttled out from the Krebs cycle [7, 13]. In the cytosol it is converted into
acetyl-CoA and oxaloacetate [3, 51]. As mentioned in the sections above, acetyl-
CoA is used as a fatty acid precursor for membrane synthesis and cell growth in
G2. This well-described pathway consumes NADPH, generated from the malic enzyme
and the pentose phosphate pathway [6]. On the other hand, oxaloacetate is converted into
malate by consuming NADH and produces NAD+. The reverse reaction occurs in mito-
chondria, where malate, shuttled-in from cytosol, is converted back to oxaloacetate during
the Krebs cycle and generates NADH, the first electron donor of ETC. This forms a full
cycle in G2 (Fig. 1-d), where NAD
+/NADH and NADP+/NADPH redox ratios both in-
crease in order to fulfill lipogenesis.
Fig. 3 Intertwined relationship between ATP/ADP ratio, the intracellular (pHi) and the transmembrane potential
(Vm). Sodium-proton exchanger (NHE-1) which extrudes a proton (H+) against a sodium (Na+) is known to
fight further cytosolic acidification. The sodium-potassium electrogenic exchanger (NaK-ATPase), one of the
main consumer of ATP in eukaryotic cells, extrudes 3 sodium (Na+) from the cytosol against 2 inward
potassium (K+) flux and creates an hyperpolyrisation of the cell membrane. Finally, Increased ΔpHi from
mitochondria matrix and intermembrane space is reported to increase ATP synthesis
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pH, which has been reported to match mitochondrial activity and described as a
potential “internal clock” for cell mitosis [52].
Intracellular pH and ATP/ADP ratio time the metabolic cell cycle
1. ATP concentration oscillations in proliferating cells
In their study, Martin and Müller [53] hypothesized that the eukaryotic cells’ common
ancestor arose from a symbiotic process between an anaerobic, autotrophic and
“strictly hydrogen-dependent archaebacterium” and a respiring eubacterium, releasing
hydrogen “as a waste product of anaerobic heterotrophic metabolism”. This symbiosis
between the hydrogen-dependent host and the symbiont, which produce hydrogen, is
an attractive hypothesis supporting P. Mitchell’s chemiosmotic theory of oxidative
phosphorylation-dependent ATP synthesis in mitochondria [49]. In this model, it is
assumed that the proton gradient across the internal membrane drives the electron
transport through the ETC. As reported above, this is performed by transmembrane
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this gradient triggers ATP synthase activity and ATP synthesis.
Further, studies explain the energy of the cell from [ATP]/[ADP] ratio point of view.
Understanding the bioenergetics of a normal dividing cell at the scale of the entire cell
cycle may bring some interesting answers to the cancer cell phenotype [7]. Interestingly,
independent studies reported the oscillation of the intracellular ATP concentration
through the cell cycle [13] and its extensive use in ionic pump activity [54]. Marcussen
and colleagues (1992) reported on ATP concentration oscillation along the progression of
the cell cycle [13]. They found that the ATP concentration is minimal at the G1/S phase
transition and then progressively reaches its maximum at G2/Mitosis (Fig. 2). This
correlates with the extensive studies by Boonstra and colleagues who reported ATP
hydrolysis-dependent Na+-K+ATPase pump activity during the G1/S transition cell
cycle [54, 55]. This pump is known to be responsible for the electric potential of large
populations of cells by extruding three Na+ and against the two K+ influx. This is con-
firmed here, where Veech and colleagues [55] showed that intracellular ATP hydroly-
sis is tightly linked to Na+-K+ATPase pump activity, responsible for the inherent
oscillation of the electrical potential of the cell [56] (Fig. 3). Consequently, ATP/ADP
ratio oscillation modulated by ATP synthesis in mitochondria and hydrolysis in the
entire cytoplasm, throughout the cell cycle, is also linked to another intracellular
oscillator, i.e., intracellular pH (pHi).
2. Intracellular pH oscillates in phase with ATP/ADP ratio
Increasing evidences indicate that the intracellular pH (pHi) homeostasis is correlated with
cell metabolism and proliferation [57–60]. Aerts and colleagues (1985) experimentally
showed an autonomous pHi cycle within a Dictyostelium cell. They managed to demon-
strate that modulating pHi controls protein synthesis and DNA replication: optimal protein
and DNA synthesis being correlated with an alkaline pHi of 7.4. This is confirmed by other
studies showing the pHi-dependent enzyme activity [61–63]. In their studies, Busa et al.
[62] showed that pHi oscillations are master regulators in the decision-making of brine
shrimp embryonic cells to enter dormancy or to continue development: the acidic pHi is
linked to dormancy, whereas the alkaline pHi is characteristic of development. In 1983,
Christen et al. highlighted the intertwined relationship between intracellular pH, ATP
hydrolysis, and mitochondrial respiration [38]. At acidic pH, the cytoplasmic activity of
dynein ATPase, which is involved in microtubule dynamics, is inhibited and the internal
ATP concentration is high, translating optimal mitochondrial respiration. On the other
hand, when pHi is alkaline, the cytoplasmic ATP concentration falls, probably due to
impaired mitochondrial respiration and increased dynein ATPase activity [64]. The authors
concluded on the cytoplasmic pH control of ATP hydrolysis, inhibited in acidic pHi and
enhanced in alkaline pHi, and mitochondrial respiration increased triggered in acidic pHi
and inhibited along with an increased alkaline pHi.
3. Intracellular pH times cell cycle entry and cell growth
The intracellular pH change can be explained by several phenomena [65]. The sodium/
hydrogen exchanger, Na+-H+-1 (NHE-1), plays a significant role, especially in pHi alka-
linization [66] (Fig. 3). Moolenaar and colleagues (1981) set up a series of experiments
showing the role of NHE-1 in regulating the pHi. Addition of sodium to a
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2000, Reshkin et al. did transfect normal cells by Human Papillomavirus (HPV), and
observed that over-expression of NHE-1 is accompanied by cytoplasmic alkalinity
which is first event of carcinogenesis. Recent studies confirm the crucial role of NHE-1
in preventing further cytoplasmic acidification [67–71]. More specifically, NHE-1 activ-
ity has been shown to be a key regulator of eukaryotic cell cycle entry and cell growth
[69, 72, 73]. Moreover, Pouysségur and colleagues (1985) showed that under growth
factor stimulation, the NHE-1 antiporter elevates the cytoplasmic pH of quiescent fi-
broblasts above a threshold of 7.2, a necessary step for cell cycle entry and DNA syn-
thesis in S phase [63]. Interestingly, some other studies showed a link between the
metabolic state of the proliferating cells and histone acetylation [73, 74] (Fig. 4).
Indeed, Histone acetylation plays a pivotal role in regulating gene accessibility to
RNA polymerase, for gene transcription [75]. Specific families of enzymes, called His-
tone Acetyltransferases (HATs) and Histone Deacetylases (HDACs), are responsible for
histone acetylation and histone deacetylation, respectively. In this study [73], the
authors reported the pivotal role of the NAD+/NADH ratio on sirtuin (HDACs) activ-
ity. The dynamics of histone acetylation has also been shown to be closely linked to
pHi [76, 77]. In this study [76], McBrian and colleagues, showed that histone acetyl-
ation has the power of regulating the pHi. The acidic pHi is indeed followed by global
histone deacetylation and, thus global histone compaction. This is typically the pheno-
type of a dormant cell such as the one described above. Conversely, the pHi increase
towards alkalinization is reported to favor global acetylation of histone, similarly to
when “resting cells are induced to proliferate”. Altogether, these results suggest the
intertwined relationship between the metabolic cell cycle balancing the NAD+/NADH
and ATP/ADP ratios through intracellular pH oscillations.Conclusion
Proliferating cells must double their biomass (proteins, lipids, and nucleic acids)
through the cell cycle in order to generate two daughter cells. For that they use the
central carbon metabolism (CCM), universally shared among living systems. The
CCM is governed by pivotal metabolic pathways such as glycolysis, the pentose
phosphate pathway, and the citric acid cycle. The cell decision-making to enter one
of these pathways is coupled to redox transitions following nutrient availability. In
the CCM, nutrients, such as glucose and glutamine, are used to generate precursors
through redox reactions and to support cell growth. Moreover, experimental studies
show that the mitochondrial activity is reduced during early progression in the cell
cycle in G1 [32]. Also, the G1 phase of the cell cycle is characterized by an anabolic
demand in protein synthesis, required for DNA replication in S phase. Synthesis of
building blocks, such as amino acids and DNA or pyruvate from carbohydrate path-
ways is then a necessary step for biomass synthesis and energy supply through mito-
chondrial activity.
Moreover, one understands that cells decision-making to enter proliferation or
stay in dormancy depends on physical, electrical and biochemical parameters.
Nutrients and growth hormones availability in the extracellular medium modulates
all these three parameters since they provoke osmotic pressure resulting in variation
Fig. 4 Intracellular pH variation and metabolic activity through the cell cycle. Resting cells have been shown to
have a basal oxidative metabolism and a pHi around 7. Cells committed to enter G1 exhibit a transient acidic
pH followed by cytosolic alkalinization. Increased pHi has been correlated with histone acetylation allowing for
DNA accessibility to RNA polymerase and protein synthesis. A pHi threshold of 7.2 has been reported for DNA
synthesis in S phase. This is followed by pHi decrease in late S phase and meet optimal ATP synthesis in
mitochondria. Follows lipid synthesis in G2. It has been suggested that a pHi drop during mitosis is linked to
microtubule disassembly by ATP hydrolysis. This results in histone deacetylation, DNA compaction and
chromosome segregation
da Veiga Moreira et al. Theoretical Biology and Medical Modelling  (2015) 12:10 Page 11 of 14in bioelectrical parameters of the cell, such as the transmembrane potential, en-
zyme and cofactors charges and the intracellular (pHi). Perturbing one of these
parameters has been reported to change the others. So that, cell metabolism
seems to be the result of intertwined state parameter oscillations. In this literature
investigation, we deciphered cell cycle progression from cell metabolism or more
precisely central carbon metabolism (CCM) point of view. It appeared, first, the
intriguing relationship between CCM and cell cycle progression, with the reactive
and oxidative (redox) cofactors such as NAD+/NADH, NADP+/NADPH being key
regulators. Secondly, as reported, mitochondria seem to be more than just a plant
for ATP synthesis. They are at the core of eukaryotic cell metabolism and cell
cycle progression. In there, the tricarboxylic acid (TCA) cycle, branched to gly-
colysis and to the pentose phosphate pathway, is central in mitochondrial metab-
olism and has been reported to match mitosis. The TCA is also an adaptive
circuit at the crossroads between cytosolic-mitochondrial energy exchanges which
are especially enhanced when resting cells are committed to divide. Finally, the
progression of the cell cycle exhibits a shifted metabolism, materialized by a shunt
from catabolism to anabolism. Transitions are performed by redox potential vari-
ation, involving NAD+/NADH, NADP+/NADPH redox couples, and ADP/ATP en-
ergetic ratios and the intracellular pH seems to the be master operator of cytosol/
mitochondrial flux balances. Understanding the dynamics of these metabolic ex-
changes will pave the way to therapeutic solutions for metabolic cycle disorders
such as cancer.
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